David Wilson


Vice President, Commercial Operations and Consultant to Industry, Mayfield, UK

Diagnostics industry executive commercialising rapid, accurate tests to detect and identify antibiotic-resistant bacteria in hospital-acquired infections, such as MRSA in hospital screening programmes, and other antibiotic-resistant pathogens causing life-threatening infections such as sepsis. Currently working on a sepsis test that will enable the early use of appropriate antibiotics to reduce mortality from sepsis, and to reduce the use of inappropriate antibiotics and associated resistance.

Share thisShare on FacebookTweet about this on TwitterEmail this to someone
The British Society for Antimicrobial Chemotherapy (BSAC)
© 2018 Registered Charity 1093118.

Registered as a company limited by guarantee in England & Wales No: 4443910

By using this site, you agree to using cookies.
For more details about cookies and how to disable them, see resource here
Privacy Policy